FDA warning: CBD not legal to treat opioid addiction

The Food and Drug Administration (FDA) has sent out a warning letter, including to a Washington company, warning them against marketing products illegally as a proven treatment for medical conditions, including opioid addiction or as an alternative to opioids.

In a news release, FDA officials said warning letters were issued to two companies for illegally selling unapproved products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act).

FDA officials explained in the release that, “the FDA has not approved any CBD products other than one prescription human drug product to treat rare, severe forms of epilepsy.”


Leave a Reply